Market Cap 31.45M
Revenue (ttm) 650,000.00
Net Income (ttm) -51.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,967.69%
Debt to Equity Ratio 0.00
Volume 42,100
Avg Vol 366,350
Day's Range N/A - N/A
Shares Out 20.16M
Stochastic %K 44%
Beta N/A
Analysts Strong Sell
Price Target $15.25

Company Profile

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeuti...

Industry: Biotechnology
Sector: Healthcare
Phone: 617-651-8867
Address:
One Kendall Square, 3rd Floor Building 1400 West, Cambridge, United States
builderup
builderup Jun. 27 at 11:49 AM
$SKYE not a bad 4 day run. $CAMP $INTS
0 · Reply
Fib7867
Fib7867 Jun. 26 at 7:55 PM
$CAMP #myCAMPanalysis
0 · Reply
StockScanners
StockScanners Jun. 25 at 4:28 AM
$CAMP Reached 1.81, keep watch
0 · Reply
builderup
builderup Jun. 24 at 7:45 PM
Nice 2 day run. Let’s keep it going! Scaling out but still strong. Patience $CAMP $SKYE $INTS
0 · Reply
StockScanners
StockScanners Jun. 23 at 11:00 PM
$CAMP keep watch if this holds above 1.60
1 · Reply
builderup
builderup Jun. 23 at 9:44 AM
Weekly watch list… $CAMP $SKYE $INTS Weekly watchlist
1 · Reply
PenkeTrading
PenkeTrading Jun. 17 at 6:29 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of CAMP4 THERAPEUTICS CORPORATION. Is that bullish or bearish? $CAMP #RsiOversold #NASDAQ
0 · Reply
jacobm50
jacobm50 May. 30 at 5:33 PM
$CAMP yes.. I can feel the momentum 😴😴😴
0 · Reply
BioTechHealthX
BioTechHealthX May. 30 at 3:20 PM
$CAMP Following its $75M IPO, CAMP4 is gaining momentum in the biotech world with breakthrough therapies for rare and neurodegenerative diseases. https://biotechhealthx.com/biotech-news/camp4-therapeutics-camp-is-game-changer-in-rna-driven-drug-discovery/
0 · Reply
jacobm50
jacobm50 May. 27 at 7:23 PM
$CAMP I’m in at 2. Let’s ride
1 · Reply
Latest News on CAMP
CAMP4 to Participate in Upcoming Investor Conferences

Feb 6, 2025, 8:00 AM EST - 5 months ago

CAMP4 to Participate in Upcoming Investor Conferences


CAMP4 Reports Third Quarter 2024 Financial Results

Nov 21, 2024, 4:05 PM EST - 7 months ago

CAMP4 Reports Third Quarter 2024 Financial Results


CAMP4 Analyst Highlights Rare Disease Platform Potential

Nov 5, 2024, 3:06 PM EST - 8 months ago

CAMP4 Analyst Highlights Rare Disease Platform Potential


CAMP4 Announces Pricing of Initial Public Offering

Oct 10, 2024, 7:07 PM EDT - 9 months ago

CAMP4 Announces Pricing of Initial Public Offering


Camp4 Therapeutics Targets IPO On Early Positive Results

Oct 1, 2024, 4:30 PM EDT - 9 months ago

Camp4 Therapeutics Targets IPO On Early Positive Results


Kaiser Permanente-backed biopharma CAMP4 files for US IPO

Sep 20, 2024, 2:23 PM EDT - 9 months ago

Kaiser Permanente-backed biopharma CAMP4 files for US IPO


CAMP4 Therapeutics IPO Registration Document (S-1)

Sep 20, 2024, 1:35 PM EDT - 9 months ago

CAMP4 Therapeutics IPO Registration Document (S-1)


builderup
builderup Jun. 27 at 11:49 AM
$SKYE not a bad 4 day run. $CAMP $INTS
0 · Reply
Fib7867
Fib7867 Jun. 26 at 7:55 PM
$CAMP #myCAMPanalysis
0 · Reply
StockScanners
StockScanners Jun. 25 at 4:28 AM
$CAMP Reached 1.81, keep watch
0 · Reply
builderup
builderup Jun. 24 at 7:45 PM
Nice 2 day run. Let’s keep it going! Scaling out but still strong. Patience $CAMP $SKYE $INTS
0 · Reply
StockScanners
StockScanners Jun. 23 at 11:00 PM
$CAMP keep watch if this holds above 1.60
1 · Reply
builderup
builderup Jun. 23 at 9:44 AM
Weekly watch list… $CAMP $SKYE $INTS Weekly watchlist
1 · Reply
PenkeTrading
PenkeTrading Jun. 17 at 6:29 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of CAMP4 THERAPEUTICS CORPORATION. Is that bullish or bearish? $CAMP #RsiOversold #NASDAQ
0 · Reply
jacobm50
jacobm50 May. 30 at 5:33 PM
$CAMP yes.. I can feel the momentum 😴😴😴
0 · Reply
BioTechHealthX
BioTechHealthX May. 30 at 3:20 PM
$CAMP Following its $75M IPO, CAMP4 is gaining momentum in the biotech world with breakthrough therapies for rare and neurodegenerative diseases. https://biotechhealthx.com/biotech-news/camp4-therapeutics-camp-is-game-changer-in-rna-driven-drug-discovery/
0 · Reply
jacobm50
jacobm50 May. 27 at 7:23 PM
$CAMP I’m in at 2. Let’s ride
1 · Reply
JarvisFlow
JarvisFlow May. 27 at 11:30 AM
Wedbush has adjusted their stance on Camp4 Therapeutics ( $CAMP ), setting the rating to Outperform with a target price of 8.
0 · Reply
HolyShnikes
HolyShnikes May. 23 at 7:43 PM
$CAMP the price action on this is fucky
0 · Reply
Ecostate
Ecostate May. 22 at 5:31 AM
$CAMP good place to be loading again. it was literally 2.30 yesterday.
0 · Reply
Green_dillo
Green_dillo May. 18 at 3:48 AM
$CAMP looking good
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 16 at 7:17 PM
$CAMP I told u... $2.36 to break next.... Green on this one waiting for more🚨🚨
0 · Reply
Green_dillo
Green_dillo May. 16 at 6:44 PM
$CAMP alerts going off
0 · Reply
BioTuesdays
BioTuesdays May. 16 at 1:34 PM
CAMP4 presents translational data from SYNGAP1-related disorders program at ASGCT annual meeting $CAMP https://biotuesdays.com/2025/05/16/camp4-presents-translational-data-from-syngap1-related-disorders-program-at-asgct-annual-meeting/
0 · Reply
DonCorleone77
DonCorleone77 May. 16 at 10:55 AM
$CAMP Camp4 Therapeutics delivers three presentantions on SYNGAP1-related disorders CAMP4 Therapeutics delivered three oral presentations on its SYNGAP1-related disorders and Urea Cycle Disorders, or UCDs, programs and shared favorable safety and pharmacokinetics data from the ongoing Phase 1 trial of CMP-CPS-001 in healthy volunteers at the 28th Annual Meeting of the American Society of Gene and Cell Therapy, taking place in New Orleans, May 13-17. Key findings for each program are as follows: In haploinsufficient mice carrying a single copy of the human SYNGAP1 gene, intracerebroventricular, or ICV, injection of CMP-SYNGAP-01, a development candidate targeting a regulatory RNA sequence mapped to a SYNGAP1 gene regulatory region, resulted in: Restored SYNGAP1 protein levels to near normal range after a single dose; rescue of motor defects and spatial learning defects following two doses, in NHPs, biweekly intrathecal injections of CMP-SYNGAP-01 resulted in a ~1.5-fold increase in SYNGAP1 protein levels across multiple brain regions clinically relevant to the disease; Dose-linear increase in CMP-SYNGAP-01 in disease-relevant brain regions CMP-SYNGAP-01 was well tolerated. The presentations can be accessed on the CAMP4 website.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 15 at 5:37 PM
$CAMP that dip was beautiful! $2.07 major resistance to break for a shot at $2.30🚨🚨
0 · Reply
Ecostate
Ecostate May. 15 at 3:50 PM
$CAMP Explosively parabolic comes this way
0 · Reply
RandyAcid
RandyAcid May. 15 at 1:39 PM
$CAMP in at 1.86 Let’s go!
0 · Reply
Stocktwit247
Stocktwit247 May. 15 at 10:55 AM
$CAMP HarbourVest Parters bought in yesterday SEC filing.. 1.3million shares. They’re a BIG deal
1 · Reply